Correlation between the number of lymph node metastases and lung metastasis in papillary thyroid cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 12, 2012, Pages 4375-4382

  Machens, Andreas ^a   Dralle, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER PROGNOSIS; CANCER STAGING; DISTANT METASTASIS; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SKIN METASTASIS; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADULT; AGED; CARCINOMA; CELL COUNT; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 84870749777     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1257     Document Type: Article

References (30)

1. American Joint Committee on Cancer 2009 AJCC cancer staging manual. 7th ed. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. New York: Springer
2. International Union Against Cancer (UICC) 2009 TNM classification of malignant tumours. 7th ed. In: Sobin LH, Gospodarowicz MK, Wittekind CH, eds. Oxford, UK: Wiley-Blackwell
3. Machens A, Dralle H 10 September 2012 Prognostic impact of N staging in 715 medullary thyroid cancer patients: proposal for a revised staging system. Ann Surg doi: 10.1097/SLA.0b013e318268301d
4. Machens A, Hauptmann S, Dralle H 2009 Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer. Surgery 145:176-181
5. Xiao GZ, Gao L 2010 Central lymph node metastasis: is it a reliable indicator of lateral node involvement in papillary thyroid carcinoma? World J Surg 34:237-241
6. Machens A, Hinze R, Thomusch O, Dralle H 2002 Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26:22-28 (Pubitemid 36918813)
7. Lee YS, Lim YS, Lee JC, Wang SG, Kim IJ, Son SM, Lee BJ 2011 Clinical implications of bilateral lateral cervical lymph node metastasis in papillary thyroid cancer: a risk factor for lung metastasis. Ann Surg Oncol 18:3486-3492
8. Akslen LA, Myking AO, Salvesen H, Varhaug JE 1992 Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. Eur J Cancer 29A:44-51
9. Yamashita H, Noguchi S, Murakami N, Kawamoto H, Watanabe S 1997 Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma. Cancer 80:2268-2272 (Pubitemid 28007398)
10. Ito Y, Hirokawa M, Jikuzono T, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A 2007 Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma. World J Surg 31:1194-1201 (Pubitemid 47029930)
11. Leboulleux S, Rubino C, Baudin E, Caillou B, Hartl DM, Bidart JM, Travagli JP, Schlumberger M 2005 Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90:5723-5729 (Pubitemid 41415482)
12. Machens A, Dralle H 2009 Prediction of mediastinal lymph node metastasis in papillary thyroid cancer. Ann Surg Oncol 16:171-176
13. Elisei R, Molinaro E, Agate L, Bottici V, Masserini L, Ceccarelli C, Lippi F, Grasso L, Basolo F, Bevilacqua G, Miccoli P, Di Coscio G, Vitti P, Pacini F, Pinchera A 2010 Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. J Clin Endocrinol Metab 95:1516-1527
14. Kouvaraki MA, Lee JE, Shapiro SE, Sherman SI, Evans DB 2004 Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. Surgery 136:1183-1191 (Pubitemid 39647532)
15. Famakinwa OM, Roman SA, Wang TS, Sosa JA 2010 ATA practice guidelines for the treatment of differentiated thyroid cancer: were they followed in the United States? Am J Surg 199:189-198
16. Dralle H, Damm I, Scheumann GF, Kotzerke J, Kupsch E, Geerlings H, Pichlmayr R 1994 Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today 24:112-121 (Pubitemid 24081294)
17. Dralle H 2002 Lymph node dissection and medullary thyroid carcinoma. Br J Surg 89:1073-1075 (Pubitemid 34989210)
18. Dralle H 2006 Malignant thyroid tumors. In: Garbe C, Albers P, Beckmann MW, Bokemeyer C, Bootz F, Creutzig U, Drings P, Gabbert HE, Heimpel H, Hohenberger W, Howaldt HP, Kloke M, Schackert G, Schmiegel W, Weller M, Wiegel T, eds. Deutsche Krebsgesellschaft e.V. Abbreviated interdisciplinary guidelines 2006. Recommendations for diagnosis and therapy of malignant diseases [in German]. Munich: W. Zuckschwerdt Verlag; 53-69
19. World Health Organization 1988 International histological classification of tumours. 2nd ed. Berlin: Springer
20. 2004 World Health Organization classification of tumours: pathology and genetics of tumours of endocrine organs. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. Lyon, France: IARC Press
21. Silver CE, Owen RP, Rodrigo JP, Rinaldo A, Devaney KO, Ferlito A 2011 Aggressive variants of papillary thyroid carcinoma. Head Neck 33:1052-1059
22. Kaplan EL, Meier P 1958 Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
23. Lang BH, Chow SM, Lo CY, Law SC, Lam KY 2007 Staging systems for papillary thyroid carcinoma. A study of 2 tertiary referral centers. Ann Surg 246:114-121 (Pubitemid 47012215)
24. Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, Brokhin M, Omry G, Fagin JA, Shaha A 2010 Estimating risk of recurrence in differentiated cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid 20:1341-1349
25. Shah PK, Shah KK, Karakousis GC, Reinke CE, Kelz RR, Fraker DL 2012 Regional recurrence after lymphadenectomy for clinically evident lymph node metastases from papillary thyroid cancer: a cohort study. Ann Surg Oncol 19:1453-1459
26. Bonnet S, Hartl D, Leboulleux S, Baudin E, Lumbroso JD, Al Ghuzlan A, Chami L, Schlumberger M, Travagli JP 2009 Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab 94:1162-1167
27. Clayman GL, Shellenberger TD, Ginsberg LE, Edeiken BS, El-Naggar AK, Sellin RV, Waguespack SG, Roberts DB, Mishra A, Sherman SI 2009 Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma. Head Neck 31:1152-1163
28. Porterfield JR, Factor DA, Grant CS 2009 Operative technique for modified radical neck dissection in papillary thyroid carcinoma. Arch Surg 144:567-574
29. Ricarte-Filho J, Ganly I, Rivera M, Katabi N, Fu W, Shaha A, Tuttle RM, Fagin JA, Ghossein R 2012 Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension. Thyroid 22:575-584
30. Popadich A, Levin O, Lee JC, Smooke-Praw S, Ro K, Fazel M, Arora A, Tolley NS, Palazzo F, Learoyd DL, Sidhu S, Delbridge L, Sywak M, Yeh MW 2011 A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. Surgery 150:1048-1057